Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04892680 · ClinicalTrials.gov registry record · NA

Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 Diabetes

A NA study, sponsored by Omada Health.

Terminated
Registry status
NA
Development phase
27
Enrollment target

NCT04892680: Clinical Trial NA study, sponsored by Omada Health.

NCT04892680 is a NA study that was terminated before completion, run by Omada Health. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04892680, a NA study, was terminated before completion, sponsored by Omada Health.

TERMINATED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

The goal of this study is to evaluate a digital chronic disease self-management program designed to provide virtual support and guidance for patients with type 2 diabetes.

Interventions

  • BEHAVIORAL Online Diabetes Self-Management Education and Support (DSMES) Program

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2021-03-04
Est. Completion 2021-08-02
Phase NA

Sponsor

Omada Health

4 total trials

What the Registry Record Tells You About NCT04892680

The ClinicalTrials.gov registry entry for NCT04892680 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Omada Health, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Online Diabetes Self-Management Education and Support (DSMES) Program is the first listed.

NCT04892680 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04892680 about?

NCT04892680 is a clinical study titled "Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 Diabetes". The goal of this study is to evaluate a digital chronic disease self-management program designed to provide virtual support and guidance for patients with type 2 diabetes.

What is the current status of trial NCT04892680?

This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2021-03-04. Estimated completion is 2021-08-02.

What interventions are being tested in trial NCT04892680?

The interventions under investigation include: Online Diabetes Self-Management Education and Support (DSMES) Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04892680?

This trial is sponsored by Omada Health, which has 4 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.